Safety monitoring and reporting
Structured support for adverse-event reporting, case prioritisation, and local risk communication.
Pharmacovigilance
Pharmacovigilance services for drug safety and regulatory compliance in Nigeria.
MedNova supports case processing, signal detection, literature monitoring, and QPPV readiness so organisations can meet local safety obligations with confidence.
Safety oversight for local and regional markets
We help life sciences teams establish the documentation, review workflows, and regulatory reporting discipline required for robust pharmacovigilance operations in Nigeria and across Africa.
Overview
Drug safety support built for practical compliance
Our pharmacovigilance service helps companies fulfil safety reporting requirements while strengthening processes for case handling, signal management, and risk communication.
ICSR and case processing
We support adverse-event intake, assessment, reporting, and record-keeping to meet local and international notification expectations.
Signal and risk management
We help teams identify safety signals, evaluate risks, and prepare the documentation needed for regulatory follow-up and lifecycle oversight.
Core support areas
What our pharmacovigilance services include
QPPV readiness
Guidance for organizing responsibilities, oversight documentation, and compliance readiness for the Qualified Person for Pharmacovigilance.
Literature monitoring
Support for monitoring safety literature, identifying relevant reports, and integrating findings into the pharmacovigilance workflow.
Regulatory safety alignment
Advice on local reporting obligations, NAFDAC requirements, and connections between safety data and regulatory filings.
FAQ
Common questions about our pharmacovigilance services
What local safety reporting does MedNova support?
We support adverse event intake, case assessment, ICSR submission, signal review, and documentation for safety-related regulatory obligations.
How does MedNova help with QPPV readiness?
We help organisations document oversight responsibilities, establish review workflows, and prepare for the regulatory expectations of a Qualified Person for Pharmacovigilance.
Can pharmacovigilance integrate with regulatory affairs?
Yes. We connect pharmacovigilance work with regulatory submissions, product registration, and lifecycle management so safety and compliance remain aligned.
Build a stronger drug safety programme
MedNova helps teams meet pharmacovigilance obligations while improving safety oversight and regulatory readiness across Nigeria and Africa.
Practical next step: For teams that want to turn this guidance into action, MedNova offers training and consulting and a downloadable checklist PDF that help connect regulatory readiness, safety, and documentation practices.